Medicare Enrolled
Dr. Samish Dhungana, MD
Neurology · Maruetta, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhungana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhungana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhungana
Dr. Samish Dhungana is a neurology specialist in Maruetta, GA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Dhungana performed 7,815 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dhungana received a total of $8,439 from 68 pharmaceutical and/or device companies across 491 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhungana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 13% volume in GA
$8,439 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,815
Medicare services
Top 13% in GA for neurology
Not available
Unique patients (not deduplicated)
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
6,780 | $4 | $12 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $58 | $198 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
130 | $122 | $378 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
128 | $97 | $286 |
| Limited needle EMG of arm or leg muscles A test that measures the electrical activity in specific muscles of the arm or leg using a needle electrode. This limited study evaluates muscle function in a targeted area. |
104 | $47 | $157 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
101 | $43 | $142 |
| VEEG monitoring, 12-26 hours with review This procedure involves monitoring brain wave activity along with video recording for 12 to 26 hours. A healthcare professional reviews the data and provides a report. |
49 | $164 | $500 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
46 | $67 | $250 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
36 | $111 | $403 |
| Video EEG monitoring, 2-12 hours This procedure records brain wave activity while simultaneously capturing video footage for a duration of 2 to 12 hours. A healthcare professional reviews the data and provides a report. |
29 | $106 | $281 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
28 | $43 | $142 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
16 | $127 | $507 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
13 | $164 | $604 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
13 | $186 | $679 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,439
Total received (2018-2024)
Avg $1,206/year across 7 years
Top 29% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
491
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,368
2023
$1,381
2022
$1,024
2021
$1,084
2020
$617
2019
$1,754
2018
$1,211
Payments by company (2024)
ABBVIE INC.
$296
Celgene Corporation
$185
EMD Serono, Inc.
$164
Alexion Pharmaceuticals, Inc.
$111
UCB, Inc.
$84
ACADIA Pharmaceuticals Inc
$70
MDD US Operations, LLC
$55
PFIZER INC.
$52
Grifols USA, LLC
$50
MITSUBISHI TANABE PHARMA AMERICA, INC.
$44
Eisai Inc.
$43
SK Life Science, Inc.
$32
Otsuka America Pharmaceutical, Inc.
$29
Alnylam Pharmaceuticals Inc.
$24
Octapharma USA, Inc.
$22
Neurocrine Biosciences, Inc.
$20
Lilly USA, LLC
$19
Lundbeck LLC
$19
Teva Pharmaceuticals USA, Inc.
$18
Novartis Pharmaceuticals Corporation
$16
Vanda Pharmaceuticals Inc.
$15
Top 3 companies account for 47.1% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$862
EMD Serono, Inc.
$669
ABBVIE INC.
$566
ACADIA Pharmaceuticals Inc
$390
Amgen Inc.
$384
Celgene Corporation
$315
Alexion Pharmaceuticals, Inc.
$314
Supernus Pharmaceuticals, Inc.
$310
Novartis Pharmaceuticals Corporation
$291
UCB, Inc.
$286
Biogen, Inc.
$209
Sunovion Pharmaceuticals Inc.
$202
Teva Pharmaceuticals USA, Inc.
$194
GENZYME CORPORATION
$191
Allergan, Inc.
$184
GE HEALTHCARE
$163
Allergan Inc.
$162
Acorda Therapeutics, Inc
$149
Eisai Inc.
$142
Neurelis, Inc.
$139
Lundbeck LLC
$136
PFIZER INC.
$133
Avanir Pharmaceuticals, Inc.
$117
Otsuka America Pharmaceutical, Inc.
$116
Grifols USA, LLC
$104
UPSHER-SMITH LABORATORIES LLC
$102
EISAI INC.
$102
Janssen Pharmaceuticals, Inc
$94
Neurocrine Biosciences, Inc.
$89
GE Healthcare
$82
CSL Behring
$77
Biohaven Pharmaceuticals, Inc.
$76
Promius Pharma LLC
$60
E.R. Squibb & Sons, L.L.C.
$57
MDD US Operations, LLC
$55
ARGENX US, INC.
$54
Octapharma USA, Inc.
$53
Adamas Pharmaceuticals, Inc.
$53
Biohaven Pharmaceutical Holding Company Ltd.
$51
ARBOR PHARMACEUTICALS, INC.
$49
JAZZ PHARMACEUTICALS INC.
$48
MITSUBISHI TANABE PHARMA AMERICA, INC.
$44
Genentech USA, Inc.
$41
AQUESTIVE THERAPEUTICS, INC.
$41
Alnylam Pharmaceuticals Inc.
$38
SK Life Science, Inc.
$32
Kyowa Kirin, Inc.
$31
Egalet US Inc
$27
Bayer HealthCare Pharmaceuticals Inc.
$26
Almatica Pharma LLC
$26
Greenwich Biosciences, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$24
Amneal Pharmaceuticals LLC
$23
Sumitomo Pharma America, Inc.
$21
Bausch Health US, LLC
$20
BANNER LIFE SCIENCES, LLC
$19
Lilly USA, LLC
$19
Assertio Therapeutics, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Mallinckrodt Enterprises LLC
$15
Vanda Pharmaceuticals Inc.
$15
GE HealthCare
$14
LivaNova USA, Inc.
$14
Arbor Pharmaceuticals, Inc.
$13
Upsher-Smith Laboratories LLC
$12
Zyla Life Sciences
$12
Medtronic USA, Inc.
$11
Impax Laboratories, Inc.
$11
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COMIRNATY · COPAXONE · DUOPA · Epidiolex · Evrysdi · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · Leqembi · MAVENCLAD · MIGRANAL · Mavenclad · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONPATTRO · Ongentys · PANZYGA · PONVORY · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Soliris · Solitaire · TECFIDERA · TOPIRAMATE EXTENDED RELEASE CAPSULES · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy SenTiva Model 1000 Generator · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · XYWAV · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
219
County median income
$98,712
Nearest hospital to ZIP centroid (approximate)
WELLSTAR KENNESTONE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhungana is a mixed practice specialist, with above-average Medicare volume (top 13% in GA), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhungana experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Dhungana performed 6,780 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dhungana receive payments from pharmaceutical companies?
Yes. Dr. Dhungana received a total of $8,439 from 68 companies across 491 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhungana's costs compare to other neurologists in Maruetta?
Dr. Dhungana's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhungana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Maruetta
Browse neurologists in Maruetta ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology